Veradigm Inc (MDRX)
10.99
+0.48
(+4.57%)
USD |
OTCM |
Nov 21, 15:59
Veradigm Max Drawdown (5Y): 74.06% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 74.06% |
September 30, 2024 | 74.06% |
August 31, 2024 | 74.06% |
July 31, 2024 | 74.06% |
June 30, 2024 | 74.06% |
May 31, 2024 | 74.06% |
April 30, 2024 | 74.06% |
March 31, 2024 | 74.06% |
February 29, 2024 | 74.06% |
January 31, 2024 | 68.68% |
December 31, 2023 | 68.68% |
November 30, 2023 | 68.68% |
October 31, 2023 | 68.68% |
September 30, 2023 | 68.68% |
August 31, 2023 | 68.68% |
July 31, 2023 | 68.68% |
June 30, 2023 | 68.68% |
May 31, 2023 | 68.68% |
April 30, 2023 | 68.68% |
March 31, 2023 | 68.68% |
February 28, 2023 | 68.68% |
January 31, 2023 | 68.68% |
December 31, 2022 | 68.68% |
November 30, 2022 | 68.68% |
October 31, 2022 | 68.68% |
Date | Value |
---|---|
September 30, 2022 | 68.68% |
August 31, 2022 | 68.68% |
July 31, 2022 | 68.68% |
June 30, 2022 | 68.68% |
May 31, 2022 | 68.68% |
April 30, 2022 | 68.68% |
March 31, 2022 | 68.68% |
February 28, 2022 | 68.68% |
January 31, 2022 | 68.68% |
December 31, 2021 | 68.68% |
November 30, 2021 | 68.68% |
October 31, 2021 | 68.68% |
September 30, 2021 | 68.68% |
August 31, 2021 | 68.68% |
July 31, 2021 | 68.68% |
June 30, 2021 | 68.68% |
May 31, 2021 | 68.68% |
April 30, 2021 | 68.68% |
March 31, 2021 | 68.68% |
February 28, 2021 | 68.68% |
January 31, 2021 | 68.68% |
December 31, 2020 | 68.68% |
November 30, 2020 | 68.68% |
October 31, 2020 | 68.68% |
September 30, 2020 | 68.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
55.53%
Minimum
Nov 2019
74.06%
Maximum
Feb 2024
68.61%
Average
68.68%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
LifeMD Inc | 96.24% |
TruBridge Inc | 79.46% |
Streamline Health Solutions Inc | 94.45% |
LENZ Therapeutics Inc | -- |
Oruka Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -13.11 |
Beta (5Y) | 0.6012 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 46.95% |
Historical Sharpe Ratio (5Y) | -0.114 |
Historical Sortino (5Y) | -0.2171 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.91% |